144 related articles for article (PubMed ID: 21236235)
1. Monitoring the safety of influenza A (H1N1) vaccine using web-based intensive monitoring.
Härmark L; van Hunsel F; Hak E; van Grootheest K
Vaccine; 2011 Feb; 29(10):1941-7. PubMed ID: 21236235
[TBL] [Abstract][Full Text] [Related]
2. Immunization-safety monitoring systems for the 2009 H1N1 monovalent influenza vaccination program.
Salmon DA; Akhtar A; Mergler MJ; Vannice KS; Izurieta H; Ball R; Lee GM; Vellozzi C; Garman P; Cunningham F; Gellin B; Koh H; Lurie N;
Pediatrics; 2011 May; 127 Suppl 1():S78-86. PubMed ID: 21502251
[TBL] [Abstract][Full Text] [Related]
3. Safety of influenza A (H1N1) 2009 monovalent vaccines - United States, October 1-November 24, 2009.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2009 Dec; 58(48):1351-6. PubMed ID: 20010511
[TBL] [Abstract][Full Text] [Related]
4. Adverse events following influenza A (H1N1) 2009 monovalent vaccines reported to the Vaccine Adverse Event Reporting System, United States, October 1, 2009-January 31, 2010.
Vellozzi C; Broder KR; Haber P; Guh A; Nguyen M; Cano M; Lewis P; McNeil MM; Bryant M; Singleton J; Martin D; DeStefano F
Vaccine; 2010 Oct; 28(45):7248-55. PubMed ID: 20850534
[TBL] [Abstract][Full Text] [Related]
5. Italian post-marketing surveillance for adverse event reports after MF59-adjuvanted H1N1v vaccination.
Parretta E; Ianniello B; Ferrazin F; Rossi F; Capuano A
Vaccine; 2011 May; 29(20):3708-13. PubMed ID: 21406267
[TBL] [Abstract][Full Text] [Related]
6. Adverse events following immunization (AEFI) with the novel influenza a (H1N1) 2009 vaccine: findings from the national registry of all vaccine recipients and AEFI and the passive surveillance system in South Korea.
Kim JH; Cho HY; Hennessey KA; Lee HJ; Bae GR; Kim HC
Jpn J Infect Dis; 2012; 65(2):99-104. PubMed ID: 22446114
[TBL] [Abstract][Full Text] [Related]
7. Safety monitoring of Influenza A/H1N1 pandemic vaccines in EudraVigilance.
Kurz X; Domergue F; Slattery J; Segec A; Szmigiel A; Hidalgo-Simon A
Vaccine; 2011 Jun; 29(26):4378-87. PubMed ID: 21501644
[TBL] [Abstract][Full Text] [Related]
8. Vaccine safety.
Labadie J
Int J Risk Saf Med; 2011; 23(2):113-5. PubMed ID: 21673419
[TBL] [Abstract][Full Text] [Related]
9. Monitoring adverse events of vaccines against Mexican flu.
van Puijenbroek EP; van Grootheest AC
Int J Risk Saf Med; 2011; 23(2):81-7. PubMed ID: 21673415
[TBL] [Abstract][Full Text] [Related]
10. The reporting completeness of a passive safety surveillance system for pandemic (H1N1) 2009 vaccines: a capture-recapture analysis.
Huang WT; Huang WI; Huang YW; Hsu CW; Chuang JH
Vaccine; 2012 Mar; 30(12):2168-72. PubMed ID: 22265861
[TBL] [Abstract][Full Text] [Related]
11. Adverse events associated with the 2009 H1N1 influenza vaccination and the vaccination coverage rate in health care workers.
Park SW; Lee JH; Kim ES; Kwak YG; Moon CS; Yeom JS; Lee JH; Lee CS
Am J Infect Control; 2011 Feb; 39(1):69-71. PubMed ID: 21122948
[TBL] [Abstract][Full Text] [Related]
12. Spontaneous reporting of adverse events following immunisation against pandemic influenza in Denmark November 2009-March 2010.
Folkenberg M; Callréus T; Svanström H; Valentiner-Branth P; Hviid A
Vaccine; 2011 Feb; 29(6):1180-4. PubMed ID: 21172382
[TBL] [Abstract][Full Text] [Related]
13. Monitoring vaccine safety during an influenza pandemic.
Iskander J; Haber P; Herrera G
Yale J Biol Med; 2005 Oct; 78(5):265-75. PubMed ID: 17132333
[TBL] [Abstract][Full Text] [Related]
14. Safety of MF-59 adjuvanted vaccine for pandemic influenza: results of the vaccination campaign in an Italian health district.
Cristiani C; Tuccori M; Pepe P; Sarteschi A; Maddalo F; Simonini G; Michi P; Consigli V; Fornai M; Antonioli L; Blandizzi C
Vaccine; 2011 Apr; 29(18):3443-8. PubMed ID: 21396903
[TBL] [Abstract][Full Text] [Related]
15. A cluster of nonspecific adverse events in a military reserve unit following pandemic influenza A (H1N1) 2009 vaccination-possible stimulated reporting?
McNeil MM; Arana J; Stewart B; Hartshorn M; Hrncir D; Wang H; Lamias M; Locke M; Stamper J; Tokars JI; Engler RJ
Vaccine; 2012 Mar; 30(14):2421-6. PubMed ID: 22310205
[TBL] [Abstract][Full Text] [Related]
16. Pandemic 2009 influenza H1N1 virus vaccination: compliance and safety in a single hemodialysis center.
Stavroulopoulos A; Stamogiannos G; Aresti V
Ren Fail; 2010; 32(9):1044-8. PubMed ID: 20863207
[TBL] [Abstract][Full Text] [Related]
17. Monitoring adverse events of the vaccination campaign against influenza A (H1N1) in the Netherlands.
van Puijenbroek EP; Broos N; van Grootheest K
Drug Saf; 2010 Dec; 33(12):1097-108. PubMed ID: 21077700
[TBL] [Abstract][Full Text] [Related]
18. Design of a robust infrastructure to monitor the safety of the pandemic A(H1N1) 2009 vaccination program in Taiwan.
Huang WT; Chen WW; Yang HW; Chen WC; Chao YN; Huang YW; Chuang JH; Kuo HS
Vaccine; 2010 Oct; 28(44):7161-6. PubMed ID: 20804804
[TBL] [Abstract][Full Text] [Related]
19. Risk of fatal adverse events after H1N1 influenza vaccination.
Nakada H; Narimatsu H; Tsubokura M; Murashige N; Matsumura T; Kodama Y; Kishi Y; Kami M
Clin Infect Dis; 2010 Jun; 50(11):1548-9. PubMed ID: 20433361
[No Abstract] [Full Text] [Related]
20. [Post-licensure safety surveillance for influenza A(H1N1) pandemic vaccines: first results].
Jacquet A; Ouaret S; Kreft-Jaïs C; Castot A
Rev Prat; 2010 Dec; 60(10):1392-4. PubMed ID: 21425536
[No Abstract] [Full Text] [Related]
[Next] [New Search]